These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of peripheral blood stem cells mobilized with granulocyte colony-stimulating factor with or without prior standard-dose chemotherapy in patients with malignancy. Kobayashi N; Kasai M; Masauzi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Hashino S; Tanaka J; Imamura M Jpn J Clin Oncol; 1995 Dec; 25(6):250-7. PubMed ID: 8523821 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. Hübel K; Dale DC; Liles WC J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286 [TBL] [Abstract][Full Text] [Related]
9. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies. Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592 [TBL] [Abstract][Full Text] [Related]
10. [Recent trend of infection caused by Pseudomonas aeruginosa in patients with hematologic disorders]. Funada H Nihon Rinsho; 1991 Oct; 49(10):2381-6. PubMed ID: 1721098 [No Abstract] [Full Text] [Related]
11. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)]. Motoyoshi K Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240 [TBL] [Abstract][Full Text] [Related]
12. The use of granulocyte colony-stimulating factor does not appear to reduce recovery time in penicillin-related agranulocytosis during the treatment of endocarditis. Figueira-Coelho J; Pereira O; Picado B; Mendonça P; Neves-Costa J J Heart Valve Dis; 2010 Nov; 19(6):810-1. PubMed ID: 21214116 [No Abstract] [Full Text] [Related]
13. [Supportive therapy in cancer treatment with colony stimulating factors and evaluation of their effect]. Ohno R Gan To Kagaku Ryoho; 1992 Mar; 19(3):308-14. PubMed ID: 1371911 [TBL] [Abstract][Full Text] [Related]
14. Clinical and economic evaluation of using granulocyte colony-stimulating factor after autologous peripheral blood progenitor cell transplantation in children. González-Vicent M; Madero L; Sevilla J; Díaz MA Haematologica; 2002 Jan; 87(1):105-6. PubMed ID: 11801471 [No Abstract] [Full Text] [Related]
15. G-CSF and the management of clozapine-induced agranulocytosis. Gerson SL J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment of agranulocytosis and sepsis with granulocyte colony stimulating factor in a case of Felty's syndrome. Marfeuille M; Clerc D; Mariette X J Rheumatol; 1995 Sep; 22(9):1803-4. PubMed ID: 8523369 [No Abstract] [Full Text] [Related]
17. Gingival response to G-CSF in a patient with congenital agranulocytosis: case report. Quinn J; Shusterman S; Garcia R Pediatr Dent; 1993; 15(2):123-5. PubMed ID: 7687052 [No Abstract] [Full Text] [Related]